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ABSTRACT 
Sarcomatoid variant of urothelial carcinoma of urinary bladder is a rare tumor which exhibits epithelial and mesenchymal 
differentiation of tumor cells both morphologically and immunohistochemically. Cyclophosphamide treatment and radiation 
therapy are associated with this tumors. This tumor is considered to be the aggressive variant of transitional cell carcinomas of 
the bladder. Treatment for this aggressive tumor is radical surgical excision with chemoradiation. We report a case of 47-year-
female presenting with dysuria and hematuria. On imaging, heterogeneously enhancing hyperdense lesion in bladder was noted 
which was diagnosed as sarcomatoid urothelial carcinoma on histopathological examination.  
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arcomatoid urothelial carcinoma of urinary bladder 
accounts for approximately 0.3% of the urothelial 
tumors [1]. It is biphasic malignant neoplasm with 
both epithelial and mesenchymal components. Though 
sarcomatoid urothelial carcinoma is rare, it is more 
common than the primary sarcoma of the bladder [2]. 
These tumors are associated with history of intravesical 
cyclophosphamide therapy and radiation therapy. Grossly, 
they present as polypoidal large intraluminal masses. 
Microscopically, epithelial component of these tumors is 
represented by transitional cell carcinoma, 
adenocarcinoma, squamous cell carcinoma or small cell 
carcinoma. Mesenchymal component is represented by 
high grade spindle cell neoplasm.  
Immunohistochemically, these tumors are positive for 
both epithelial and mesenchymal markers. Though the 
definitive treatment modality has not been described due to 
availability of small number of cases, the preferred  
 
treatment is radical cystectomy with adjuvant 
chemotherapy and radiation. We, hereby, report a case of 
sarcomatoid urothelial carcinoma due its rarity. 
CASE PRESENTATION  
A 47-year-old woman presented with history of painful 
micturition and blood mixed urine for last 2 months. There 
was no other significant present or past history. On 
examination, she was afebrile, conscious with stable vital 
signs. General and systemic examination did not reveal 
any abnormality. All the biochemical parameters were 
within the normal limits.  
Ultrasound examination revealed echogenic material 
measuring 4.6X2.8X3.2cm with few calcifications, arising 
from posterior right lateral wall of the base of the bladder 
and infiltrating the right vesicoureteric junction and 
moderate right hydroureteronephrosis secondary to 
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infiltration of right vesicoureteric junction. Contrast 
enhanced computed tomography (CECT) abdomen 
revealed heterogenously enhancing hyperdense lesion 
measuring 5X3.2X4.2cm along the right lateral wall of 
urinary bladder involving vesicoureteric junction on right 
side. Mild perivesical fat stranding was noted above the 
mass causing right hydroureteronephrosis. Cystoscopy 
revealed single, solitary growth of size around 4X3cms 
over right lateral wall extending on to right ureteric orifice.  
 
Figure 1 – Tumor showing myxoid change (upper portion) 
and carcinomatous cells (lower portion) (H&E, X100) 
Radical cystectomy with ureterosigmoidostomy was 
performed and cystectomy specimen was sent for 
histopathological examination. Patient was healthy post 
operatively. Grossly cystectomy specimen was measuring 
9X8X4cms. Cut section showed nodular, firm tumor in the 
right lateral wall measuring 4.5X3.5X2cm. Cut section of 
the tumor was gray white with myxoid areas. 
Histopathological examination of the tumor revealed 
tumors cells arranged in glandular pattern, alveolar pattern 
and nesting pattern. Many foci shows spindle shaped 
tumor cells having oval elongated nuclei. Mononucleated 
and multinucleated tumor giant cells were seen. Extensive 
areas of myxoid change (Figure 1) and areas of necrosis 
were noted. On the basis of these features, the diagnosis of 
transitional cell carcinoma with sarcomatoid 
differentiation was made. 
DISCUSSION  
Sarcomatoid variant of urothelial carcinoma of urinary 
bladder is an uncommon form of malignancy where tumor 
cells exhibit histological, cytological and molecular 
features of both mesenchymal tumors (sarcoma) and 
epithelial tumors (carcinomas). The incidence of 
sarcomatoid urothelial carcinoma ranges from 0.2% to 
4.3% [3]. Mean age of presentation for these tumors is 66 
years (range 50-77 years). These tumors are associated 
with history of previous treatment with intravesical 
cyclophosphamide therapy or radiotherapy [4].  
The most common presenting features of these tumors are 
painful micturition, hematuria, lower abdominal pain and 
acute retention of urine. The most frequent location of 
sarcomatoid urothelial carcinoma is the lateral wall of the 
bladder. However, previous studies have shown the 
commonest location to be trigone of the bladder which 
gives evidence for the origin of the tumor from wolffian 
body [5].  
Macroscopic appearance of the sarcomatoid variant of 
urothelial carcinoma is large polypoidal intraluminal mass. 
Microscopically, the tumor is composed of epithelial and 
mesenchymal components. Epithelial component is 
represented by urothelial carcinoma, squamous cell 
carcinoma, adenocarcinoma and small cell carcinoma. 
Mesenchymal component is represented by high grade 
spindle cell neoplasms which can be malignant fibrous 
histiocytoma or leiomyosarcoma. Osteosarcoma and 
chondrosarcoma are the most common heterologous 
elements found in them.  
Some of these tumors exhibit prominent myxoid 
stroma as seen in our case. Due to this feature it can be 
misdiagnosed as inflammatory pseudotumor. But the 
inflammatory pseudotumors are positive for anaplastic 
lymphoma kinase stains, where as the sarcomatoid 
urothelial carcinoma is negative. On 
immunohistochemistry, epithelial component of 
sarcomatoid urothelial carcinoma stains positive for 
cytokeratins and stromal elements react with markers of 
mesenchymal differentiation (vimentin) [6]. Though the 
histogenesis of the tumor is not clear, molecular studies 
have shown that both epithelial and mesenchymal 
component of these tumors have monoclonal cell origin.   
Sarcomatoid urothelial carcinoma must be 
differentiated from other benign and locally aggressive 
lesions such as pseudosarcomatous myofibroblastic 
proliferations or post operative spindle cell nodules and 
pseudotumors of the urinary bladder (inflammatory 
myofibroblastic tumors). Pseudosarcomatous 
myofibroblastic proliferations also form large polypoidal 
mass which has high cellularity and increased mitosis but 
without atypical mitotic figures. This lesion has zonal 
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pattern of distribution with base showing increased 
cellularity and towards the surface are hypocellular and 
myxoid regions [7]. Inflammatory myofibroblastic tumors 
also show myxoid areas but they lack the carcinomatous 
elements. 
Other tumors like primary sarcomas (especially 
Leiomyosarcomas) and urothelial carcinoma with 
chondroid or osseous metaplasia should be distinguished. 
In the primary sarcomas, epithelial component will be 
absent. In the urothelial carcinoma with metaplastic 
components, there will be absence of atypia in the cartilage 
and bone [8]. These tumors are associated with poor 
prognosis and multimodality therapy is recommended. 
After surgical resection of the tumor of the urinary 
bladder, chemotherapy and chemoradiotherapy is 
recommended [9].  
CONCLUSION  
Sarcomatoid urothelial carcinoma of urinary bladder is 
rare and aggressive neoplasm that has similar clinical 
presentation as that of conventional high grade urothelial 
carcinoma, but has worse prognosis. They present at 
younger age and at an advanced stage. Radical surgery 
along with chemoradiation improves the prognosis of the 
tumor.  
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